← Back to Clinical Trials
Recruiting NCT05828797

NCT05828797 Elastography in Patients With Hemiplegia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05828797
Status Recruiting
Phase
Sponsor Sanliurfa Mehmet Akif Inan Education and Research Hospital
Condition Hemiplegia
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2024-05-05
Primary Completion 2025-01-01

Trial Parameters

Condition Hemiplegia
Sponsor Sanliurfa Mehmet Akif Inan Education and Research Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-05-05
Completion 2025-01-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In our study, we aimed to examine the muscles and tendons of the shoulder region on the plegic side of patients with hemiplegia by elastography and to investigate whether there is a relationship between the course of the disease and the course of the lesions that will occur in the shoulder.

Eligibility Criteria

Inclusion Criteria: 1. Volunteer patients 2. Patients over 18 years old 3. Patients with hemiplegia 4. Patients without any rheumatic disease 5. Patients without any neurological deficit and muscle disease 6. Not having received ftr treatment to the shoulder area in the last 3 months 7. No injection to the shoulder area in the last 3 months 8. Not having any surgical procedure on the shoulder area 9. Not to be pregnant Exclusion Criteria: 1. Patients with any rheumatic disease 2. Patients with any neurological deficit and muscle disease 3. To have received ftr treatment to the shoulder area in the last 3 months 4. Being under 18 years old 5. Having an infectious disease 6. Having any benign or malignant disease 7. Any surgical procedure to the shoulder area 8. Pregnancy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology